Health Care · Managed Health Care

Centene Corporation CNC

$63.91-0.17 (-0.27%)delayed quote · as of 2026-07-29 02:00 UTC

Open CNC in the workspaceCharts, statements, and the evidence behind every figure — free to start.

Market cap

$31.6B

Previous close

$64.08

Volume

12.2M

52-week range

$25.08 – $69.36

Verdictconfidence 92% · high

Value, Health and Momentum stand out; quality flashes caution.

4 of 5 dimensions score well; quality flashes caution.

Value753/4 checks

Growth502/4 checks

Quality402/5 checks

Health1005/5 checks

Momentum1005/5 checks

Fair-value estimate $294.06 per share (2-stage FCF · individual beta · 10Y Rf 4.4%) — the price sits 78% below it.

Every check behind these scores — with its numbers, source, and evidence link — is in the workspace. Free account required.

Key ratioslatest filing FY 2025

Value

P/E TTM

—

P/E FWD

14.3

EV/EBITDA TTM

8.4

PEG

—

FCF yield TTM

22.5%

Growth

Revenue 3y

+10.5%/yr

Revenue YoY

+19.4%

Expected EPS

—

Quality

Piotroski F

4 / 9

ROIC

-74.9%

Gross margin

7.3%

Health

Altman Z

2.76

Current ratio

1.10

Debt/equity

0.87

Momentum

vs 50-day

+64.8%

vs 200-day

+75.1%

52-wk range

88%

FY 2025: revenue $194.8B · net income -$6.7B · free cash flow $4.3B (SEC EDGAR filings)

ALAN GLOBAL INTELLIGENCE · alanglobalintelligence.comquote as of 2026-07-29 02:00 UTC · fundamentals FY 2025 · SEC EDGAR

Verdict

Reading CNC’s filed statements…

Continue with CNC in ALAN

Full evidence trail, financial statements back a decade, valuation history, charts, and alerts.

Open in the workspace Create free account

For information and research only. Not investment advice. ALAN does not place trades or execute orders. Figures come from the sources shown and can lag the market; verify independently before making decisions. Past performance is not predictive of future results.